Latest Breaking News On - Jeffreyr schelling - Page 1 : comparemela.com

Investigators report promising results from a phase 2 trial of an investigational aldosterone synthase inhibitor. BI 690517, a novel investigational aldosterone synthase inhibitor, may improve clinicians’ ability to slow progression of chronic kidney disease.

United statesCase western reserve universitySanjay rastogiLos angelesJeffreyr schellingKatheriner tuttleDaniele sprattCase western reserve university school of medicineProvidence inland northwest healthOxford population healthUniversity of washington school medicineUniversity hospitals seidman cancer centerUniversity of californiaNephrology clinical research programWashington schoolCase western reserve university school